Drug Profile
Research programme: fatty acid amide hydrolase inhibitors - Adolor Corporation
Alternative Names: OL-135Latest Information Update: 11 Mar 2009
Price :
$50
*
At a glance
- Originator Adolor Corporation
- Class Small molecules
- Mechanism of Action Fatty acid amide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammatory pain
Most Recent Events
- 07 Nov 2007 Preclinical trials in Inflammatory pain in USA (PO)